TLR4 and neoplasm: Using both human and mouse in vitro assays and an in vivo mouse tumour model, we demonstrate a TLR4-dependent causative role for increased ratios of hexa-acylated LPS in the gut in enhancement of anti-PD-1-mediated anti-tumour responses.